State of New Jersey Common Pension Fund D Sells 1,124 Shares of Avantor, Inc. (NYSE:AVTR)

State of New Jersey Common Pension Fund D lowered its position in shares of Avantor, Inc. (NYSE:AVTR) by 0.5% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 246,334 shares of the company’s stock after selling 1,124 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Avantor were worth $5,190,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. State Street Corp lifted its position in shares of Avantor by 58.0% in the 3rd quarter. State Street Corp now owns 22,368,244 shares of the company’s stock worth $578,666,000 after purchasing an additional 8,206,695 shares during the period. Janus Henderson Group PLC lifted its position in shares of Avantor by 18.2% in the 3rd quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company’s stock worth $457,710,000 after purchasing an additional 2,719,615 shares during the period. Geode Capital Management LLC lifted its position in shares of Avantor by 7.1% in the 3rd quarter. Geode Capital Management LLC now owns 11,150,788 shares of the company’s stock worth $287,791,000 after purchasing an additional 739,667 shares during the period. The Manufacturers Life Insurance Company increased its stake in shares of Avantor by 653.0% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company’s stock worth $159,740,000 after acquiring an additional 5,354,678 shares in the last quarter. Finally, CCLA Investment Management increased its stake in shares of Avantor by 4.5% in the 4th quarter. CCLA Investment Management now owns 5,357,703 shares of the company’s stock worth $112,940,000 after acquiring an additional 229,199 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Stock Performance

AVTR opened at $17.73 on Thursday. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. The company has a market cap of $12.07 billion, a price-to-earnings ratio of 17.05, a PEG ratio of 1.60 and a beta of 1.28. The company’s 50 day moving average is $21.16 and its 200 day moving average is $23.05. Avantor, Inc. has a 12-month low of $17.14 and a 12-month high of $28.00.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same period in the prior year, the business earned $0.22 EPS. On average, equities research analysts predict that Avantor, Inc. will post 1.06 EPS for the current year.

Wall Street Analyst Weigh In

AVTR has been the subject of several research reports. Raymond James reiterated an “outperform” rating and issued a $24.00 price target (down from $26.00) on shares of Avantor in a research note on Monday, February 10th. Robert W. Baird reduced their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. UBS Group restated a “neutral” rating and set a $25.00 price objective (down from $29.00) on shares of Avantor in a research note on Friday, January 17th. Royal Bank of Canada reduced their price target on shares of Avantor from $33.00 to $31.00 and set an “outperform” rating for the company in a research note on Monday, February 10th. Finally, Barclays reduced their price target on shares of Avantor from $26.00 to $23.00 and set an “overweight” rating for the company in a research note on Monday, February 10th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $25.92.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.